tyrphostin a23 has been researched along with Esophageal Diseases in 1 studies
tyrphostin A23: inhibits EGF-stimulated thymidine incorporation as well as EGF-stimulated receptor autophosphorylation & tyrosine phosphorylation & cell proliferation; structure given in first source
Esophageal Diseases: Pathological processes in the ESOPHAGUS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tchorzewski, MT | 1 |
| Qureshi, FG | 1 |
| Duncan, MD | 1 |
| Duncan, KL | 1 |
| Saini, N | 1 |
| Harmon, JW | 1 |
1 other study available for tyrphostin a23 and Esophageal Diseases
| Article | Year |
|---|---|
Role of insulin-like growth factor-I in esophageal mucosal healing processes.
Topics: Animals; Catechols; Cell Division; Culture Techniques; DNA; Esophageal Diseases; Esophagus; Growth I | 1998 |